Tieron / Targeting
EDINET code list
Companies › Japanese listed company

StemCell Institute Inc.

株式会社ステムセル研究所Tokyo Stock Exchange 7096, Pharmaceutical. Supply-chain directory entry built from public EDINET filings.

COMPANY NAME (JP)
株式会社ステムセル研究所
TICKER
TSE 7096
EDINET CODE
E35563
CORPORATE NUMBER
8010401038548
INDUSTRY
Pharmaceutical (医薬品)
HEAD OFFICE
港区虎ノ門一丁目21番19号

Sector risk context: supply-chain risk by country and sector.

More Pharmaceutical companies

StemRIM Inc.Sumitomo Pharma Co., Ltd.SymBio Pharmaceuticals LimitedTAIKO PHARMACEUTICAL CO., LTD.TAUNS Laboratories, Inc.TMS Co., LtdTOWA PHARMACEUTICAL CO.,LTD.TSUMURA & CO.
Screening StemCell Institute Inc. or mapping suppliers like them? Check any company against sanctions and forced-labor lists, free.Free sanctions check →

Work at StemCell Institute Inc.? Claim this page to review the data your customers see.

Get sanctions & UFLPA list updates
A short note when the lists change in ways that matter for supply-chain screening. No noise.
Sources: EDINET code list (Financial Services Agency) and the company’s own annual securities report (有価証券報告書) retrieved via EDINET. Disclosed relationships are quoted from the filing and carry its EDINET accession number; extraction is automated and conservative — anything the filing does not state is left out. Tieron does not certify, audit or endorse the company, and this page contains no Tieron risk assessment. Report an issue with this page — corrections referencing the accession number shown above are fastest to verify.